Edition:
India

Unichem Laboratories Ltd (UNLB.NS)

UNLB.NS on National Stock Exchange of India

194.75INR
20 Sep 2019
Change (% chg)

Rs6.20 (+3.29%)
Prev Close
Rs188.55
Open
Rs187.00
Day's High
Rs201.00
Day's Low
Rs184.05
Volume
153,443
Avg. Vol
56,229
52-wk High
Rs228.00
52-wk Low
Rs160.15

Latest Key Developments (Source: Significant Developments)

Unichem Laboratories Says U.S. FDA's Inspection At Kolhapur Facility Ends Without Any Form 483 Issued
Friday, 20 Sep 2019 

Sept 20 (Reuters) - Unichem Laboratories Ltd ::UNICHEM LABORATORIES LTD - ACTIVE PHARMACEUTICAL INGREDIENTS FACILITY AT KOLHAPUR INSPECTED BY U.S. FDA AND CONCLUDED WITHOUT ANY FDA FORM 483 ISSUED.  Full Article

Unichem Laboratories Gets Receives ANDA Nod From USFDA For Solifenacin Succinate Tablets
Wednesday, 28 Aug 2019 

Aug 28 (Reuters) - Unichem Laboratories Ltd ::UNICHEM RECEIVES ANDA APPROVAL FROM USFDA FOR SOLIFENACIN SUCCINATE TABLETS, 5 MG AND 10 MG.  Full Article

India's Unichem Gets 1 Observation From USFDA Inspection Of Ghaziabad Unit
Monday, 26 Aug 2019 

Aug 26 (Reuters) - Unichem Laboratories Ltd ::U.S. FDA INSPECTED COMPANY'S GHAZIABAD FORMULATION FACILITY BETWEEN AUGUST 19, 2019 TO AUGUST 23, 2019.INSPECTION WAS A ROUTINE GMP SURVEILLANCE.AT END OF INSPECTION, FACILITY RECEIVED 1 OBSERVATION WHICH IS NOT A REPEAT OBSERVATION AND IS PROCEDURAL IN NATURE.  Full Article

Unichem Laboratories Says Goa Facility Got 4 Observations After USFDA Inspection
Wednesday, 31 Jul 2019 

July 31 (Reuters) - Unichem Laboratories Ltd ::USFDA INSPECTED COMPANY'S GOA FORMULATION FACILITY BETWEEN JULY 22 TO JULY 31, 2019.FACILITY RECEIVED 4 OBSERVATIONS, WITH NO REPEAT OBSERVATIONS AND ARE MOSTLY PROCEDURAL IN NATURE.  Full Article

Unichem Laboratories March-qtr Profit Surges
Friday, 24 May 2019 

May 24 (Reuters) - Unichem Laboratories Ltd ::RECOMMENDED DIVIDEND OF 4 RUPEES PER SHARE.MARCH QUARTER PROFIT 99.4 MILLION RUPEES VERSUS PROFIT 22.5 MILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 2.77 BILLION RUPEES VERSUS 2.03 BILLION RUPEES YEAR AGO.  Full Article

Unichem Laboratories Gets Final Approval For Tadalafil Tablets From U.S FDA
Wednesday, 27 Mar 2019 

March 27 (Reuters) - Unichem Laboratories Ltd ::GETS FINAL APPROVAL FOR ITS ANDA, TADALAFIL TABLETS, 2.5 MG, 5 MG 10 MG AND 20 MG FROM U.S FDA.  Full Article

Unichem Laboratories Gets EIR For Post Marketing Adverse Drug Experience Inspection
Monday, 26 Nov 2018 

Nov 26 (Reuters) - Unichem Laboratories Ltd ::UNICHEM LABORATORIES GETS EIR FOR POST MARKETING ADVERSE DRUG EXPERIENCE INSPECTION CONDUCTED BY USFDA FROM JUNE 25 TO JUNE 29.  Full Article

India's Unichem Labs Sept Qtr Profit Falls
Tuesday, 30 Oct 2018 

Oct 30 (Reuters) - Unichem Laboratories Ltd ::SEPT QUARTER PROFIT 152.1 MILLION RUPEES VERSUS PROFIT 458.2 MILLION RUPEES YEAR AGO.SEPT QUARTER REVENUE FROM OPERATIONS 2.46 BILLION RUPEES VERSUS 1.63 BILLION RUPEES YEAR AGO.  Full Article

Unichem Laboratories Gets ANDA Approval From U.S. FDA For Valsartan Tablets, USP
Monday, 7 May 2018 

May 7 (Reuters) - Unichem Laboratories Ltd ::SAYS GOT ANDA APPROVAL FROM USFDA FOR VALSARTAN TABLETS, USP.SAYS PRODUCT WILL BE COMMERCIALIZED FROM UNICHEM'S GHAZIABAD PLANT .  Full Article

Unichem Laboratories Seeks Shareholders' Nod For Share Buyback Proposal
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Unichem Laboratories Ltd ::SEEKS SHAREHOLDERS' NOD FOR SHARE BUYBACK PROPOSAL WORTH 8.86 BILLION RUPEES.  Full Article